☆ 4.7 Article

Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease

JOURNAL OF CLINICAL MEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Gastroenterology & Hepatology

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

Ferenc Emil Mozes et al.

Summary: Liver biopsy is still necessary for fibrosis staging in patients with non-alcoholic fatty liver disease. This study evaluated the diagnostic performance of liver stiffness measurement, FIB-4 Index, and NAFLD Fibrosis Score, and showed that sequential combinations of markers can reduce the need for liver biopsies.

GUT (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLD

Liang-Jie Tang et al.

Summary: This study evaluated the performance of new biomarkers and algorithms for diagnosing advanced fibrosis in an Asian population. The results showed that the ADAPT score had good accuracy and sensitivity in diagnosing advanced fibrosis, and it outperformed other non-invasive fibrosis biomarkers. The ADAPT score also had good diagnostic performance in subgroup analyses.

METABOLISM-CLINICAL AND EXPERIMENTAL (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care Patients

Mohammed Eslam et al.

Summary: Metabolic-associated fatty liver disease is common, with fibrosis being a major factor in predicting adverse outcomes. The newly developed ADAPT algorithm shows high accuracy in diagnosing advanced fibrosis, and when combined with LSM, it significantly reduces the need for liver biopsy with high diagnostic accuracy.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease

Stefano Ballestri et al.

Summary: Liver fibrosis can predict liver-related and cardiovascular outcomes in chronic liver disease patients. Various liver fibrosis biomarkers show good diagnostic performance for identifying significant/advanced fibrosis. Some indices perform best in predicting advanced fibrosis in patients with viral chronic liver disease and NAFLD.

DIAGNOSTICS (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

PRO-C3 and ADAPT algorithm accurately identify patients with advanced fibrosis due to alcohol-related liver disease

Bjorn S. Madsen et al.

Summary: The study aimed to evaluate the diagnostic accuracy of blood biomarkers like PRO-C3, ADAPT score, and Forns index for alcohol-related liver fibrosis. Results showed that PRO-C3 had good accuracy, with ADAPT algorithm performing better and further enhancing PRO-C3's diagnostic accuracy in detecting advanced alcohol-related liver fibrosis.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update

Annalisa Berzigotti et al.

Summary: The article provides the latest update to the EASL Clinical Practice Guidelines on the use of non-invasive tests for assessing liver disease severity and prognosis, with a focus on topics with relevant evidence published in the last 5 years.

JOURNAL OF HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Comparison of ADAPT, FIB-4 and APRI as non-invasive predictors of liver fibrosis and NASH within the CENTAUR screening population

Mette Juul Nielsen et al.

Summary: The study validated the superior performance of PRO-C3 and ADAPT for detecting moderate/severe fibrosis, with PRO-C3 being associated with liver disease activity and fibrosis. ADAPT showed better performance in selecting patients with non-alcoholic steatohepatitis for clinical trials than other non-invasive scores.

JOURNAL OF HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Natural history of NASH

Angelo Armandi et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is the fastest growing cause of chronic liver disease globally with a substantial clinical burden, affecting approximately 25% of the world population. Besides liver-related mortality, cardiovascular diseases are the most common cause of death in NAFLD patients. There is significant variability in susceptibility to liver disease among individuals.

LIVER INTERNATIONAL (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Determining a healthy reference range and factors potentially influencing PRO-C3 - A biomarker of liver fibrosis

Elisabeth Erhardtsen et al.

Summary: Through the study, the healthy reference range of PRO-C3 was established, and it was confirmed to reliably identify patients with clinically significant and advanced liver fibrosis in those with NAFLD/NASH.

JHEP REPORTS (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis

Javier Ampuero et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

Redefining non-alcoholic fatty liver disease: what's in a name?

[Anonymous]

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

ADAPT: An Algorithm Incorporating PRO-C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis

Samuel J. Daniels et al.

HEPATOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Assessment of liver fibrosis progression and regression by a serological collagen turnover profile

Morten A. Karsdal et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Collagen Formation Assessed by N-Terminal Propeptide of Type 3 Procollagen Is a Heritable Trait and Is Associated With Liver Fibrosis Assessed by Magnetic Resonance Elastography

Cyrielle Caussy et al.

HEPATOLOGY (2019)

添加到收藏夹

Article Endocrinology & Metabolism

Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes

Fernando Bril et al.

DIABETES CARE (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

PRO-C3: a new and more precise collagen marker for liver fibrosis in patients with chronic hepatitis C

Janne Fuglsang Hansen et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Liver fibrosis: Direct antifibrotic agents and targeted therapies

Detlef Schuppan et al.

MATRIX BIOLOGY (2018)

添加到收藏夹

Review Gastroenterology & Hepatology

Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis

Parambir S. Dulai et al.

HEPATOLOGY (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

Hannes Hagstrom et al.

JOURNAL OF HEPATOLOGY (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes

Zobair M. Younossi et al.

HEPATOLOGY (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Performance of the Aspartate Aminotransferase-to-Platelet Ratio Index for the Staging of Hepatitis C-Related Fibrosis: An Updated Meta-Analysis

Zhong-Hua Lin et al.

HEPATOLOGY (2011)

添加到收藏夹

Article Gastroenterology & Hepatology

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

Paul Angulo et al.

HEPATOLOGY (2007)

添加到收藏夹

Article Gastroenterology & Hepatology

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

Richard K. Sterling et al.

HEPATOLOGY (2006)

添加到收藏夹

Article Gastroenterology & Hepatology

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

DE Kleiner et al.

HEPATOLOGY (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.